SPPI — Spectrum Pharmaceuticals Share News
0.000.00%
HealthcareSpeculativeSmall Cap
- $211.40m
- $184.11m
- $10.11m
U.S. STOCKS ON THE MOVE-Costco, FedEx, Coinbase, Exxon
Advisory: Stock alert movement on Splash Beverages withdrawn
U.S. STOCKS ON THE MOVE-Costco, FedEx, U.S. metal miners, Nike
Brief: Spectrum Pharma Announces Debt Financing Agreement With SLR Capital Partners
Spectrum Pharma slumps as FDA panel votes against co's cancer drug
U.S. FDA panel votes against Spectrum's lung cancer drug (updated)
U.S. FDA panel votes against Spectrum's lung cancer drug
Spectrum Pharma slides after FDA raises concerns over lung cancer drug
U.S. FDA staff raises concerns on Spectrum Pharma's cancer drug (updated)
U.S. FDA staff raises concerns on Spectrum Pharma's cancer drug
U.S. STOCKS ON THE MOVE-Perrigo, FG Financial, Alector
U.S. STOCKS ON THE MOVE-Metal miners, Rambus, Nuwellis
U.S. STOCKS ON THE MOVE-Titan Medical, Gold miners, Relay Therapeutics
Spectrum Pharma surges on FDA approval of Rolvedon injection
Spectrum Pharma rises on FDA approval of neutropenia injection
Brief: Spectrum Pharmaceuticals Receives FDA Approval For Rolvedon Injection
Spectrum jumps after FDA completes inspection of neutropenia drug plant
Brief: Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Corporate Update
Spectrum Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary